Capillary Dysfunction and CD46-immunoreceptor (CD46) Type in MS

计划入组 83 人 · 首次发布于 2019 年 4 月 8 日

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

计划入组 20 人 · 首次发布于 2023 年 6 月 7 日

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

计划入组 75 人 · 首次发布于 2025 年 2 月 24 日

Anti-CD46 mAb(Crucell)

Anti-CD46- antibody drug conjugates(AbbVie)

Anti-CD46 antibody drug conjugate (Fortis Therapeutics)

FibroGen Rebrands as Kyntra Bio, Advances CD46-Targeting ADC and Roxadustat Programs

CD46-Targeting ADC FG-3246 Shows Promising Results in Advanced Prostate Cancer Trial

Kyntra Bio's FG-3246 ADC Shows Promising Results in Metastatic Prostate Cancer Combination Trial